|
Market Update
|
14 June 2023 at 8:20am
|
|
Notification of cessation of securities - CSL
|
8 June 2023 at 12:35pm
|
|
Shareholder Briefing
|
29 May 2023 at 9:55am
|
|
Notification of cessation of securities - CSL
|
5 May 2023 at 10:50am
|
|
Notification of cessation of securities - CSL
|
13 April 2023 at 2:40pm
|
|
Becoming a substantial holder
|
3 April 2023 at 6:45pm
|
|
Ceasing to be a substantial holder
|
28 March 2023 at 8:10pm
|
|
CSL European Investor Site Tour Presentations
|
28 March 2023 at 7:10pm
|
|
Update - Dividend/Distribution - CSL
|
14 March 2023 at 2:50pm
|
|
Application for quotation of securities - CSL
|
9 March 2023 at 1:55pm
|
|
Notification regarding unquoted securities - CSL
|
9 March 2023 at 1:55pm
|
|
Final Director's Interest Notice
|
6 March 2023 at 8:40am
|
|
Application for quotation of securities - CSL
|
2 March 2023 at 12:55pm
|
|
Notification of cessation of securities - CSL
|
2 March 2023 at 12:20pm
|
|
Change of Director's Interest Notice x 8
|
24 February 2023 at 10:40am
|
|
Notification regarding unquoted securities - CSL
|
24 February 2023 at 10:30am
|
|
Portfolio Update
|
21 February 2023 at 11:40am
|
|
Dividend/Distribution - CSL
|
14 February 2023 at 8:35am
|
|
CSL Half Year Results Announcement & Investor Presentation
|
14 February 2023 at 8:35am
|
|
CSL Statutory Accounts for the Half Year Ended 31 Dec 2022
|
14 February 2023 at 8:35am
|
|
Notification of cessation of securities - CSL
|
7 February 2023 at 11:25am
|
|
New Segment Note Historical Financial Detail
|
6 February 2023 at 8:50am
|
|
Notification of cessation of securities - CSL
|
16 January 2023 at 4:05pm
|
|
Notice of Investor/Analyst Briefing 2023 Half Year Result
|
9 January 2023 at 5:20pm
|
|
Notification of cessation of securities - CSL
|
13 December 2022 at 11:40am
|
|
Initial Director's Interest Notice
|
13 December 2022 at 11:40am
|
|
Appointment of CSLs next CEO & Managing Director
|
13 December 2022 at 8:00am
|
|
Becoming a substantial holder
|
15 November 2022 at 8:45am
|
|
Notification of cessation of securities - CSL
|
8 November 2022 at 10:00am
|
|
Change of Director's Interest Notice
|
4 November 2022 at 3:20pm
|
|
Notification regarding unquoted securities - CSL
|
4 November 2022 at 3:10pm
|
|
CSL Highlights Progress Across Strong R&D Pipeline
|
3 November 2022 at 8:40am
|
|
Licence Agreement - Next Generation mRNA Vaccine Technology
|
2 November 2022 at 9:15am
|
|
CSL Notice of Research & Development Investor Briefing
|
31 October 2022 at 10:20am
|
|
Change of Director's Interest Notice
|
25 October 2022 at 11:35am
|
|
Change of Director's Interest Notice
|
21 October 2022 at 12:40pm
|
|
CSL Vifor Market Briefing
|
17 October 2022 at 8:45am
|
|
Notification of cessation of securities - CSL
|
14 October 2022 at 2:10pm
|
|
CSL 2022 AGM Results
|
12 October 2022 at 2:10pm
|
|
CSL 2022 AGM Chair and CEO Speech and Presentation
|
12 October 2022 at 8:55am
|
|
Change of Director's Interest Notice
|
27 September 2022 at 4:50pm
|
|
Notification of cessation of securities - CSL
|
16 September 2022 at 1:10pm
|
|
Notification regarding unquoted securities - CSL
|
9 September 2022 at 4:15pm
|
|
Application for quotation of securities - CSL
|
9 September 2022 at 4:10pm
|
|
Update - Dividend/Distribution - CSL
|
9 September 2022 at 8:45am
|
|
Notification regarding unquoted securities - CSL
|
2 September 2022 at 3:05pm
|
|
Change of Director's Interest Notice
|
2 September 2022 at 3:05pm
|
|
Change of Director's Interest Notice
|
2 September 2022 at 3:05pm
|
|
Notification of cessation of securities - CSL
|
2 September 2022 at 3:05pm
|
|
Notification regarding unquoted securities - CSL
|
2 September 2022 at 3:00pm
|
CSL